BioSpace News Archive

Pharm Country

CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)

CytoSorbents Corporation announced its scientific program for the 42nd International Symposium on Intensive Care & Emergency Medicine ( ISICEM 2023) Congress being held this week in Brussels, Belgium.

March 22, 2023
·
8 min read
Business

Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. today announced that it will release its 2022 fourth-quarter and full-year financial and business results after market close on March 30, 2023.

March 22, 2023
·
1 min read
Genetown

Axena Health Receives Positive Insurance Coverage Decision From Cigna Healthcare for Leva Pelvic Health System

Axena Health, Inc. announced that Cigna Healthcare, one of the largest healthcare insurance providers in the United States with approximately 15 million members, has added the Leva Pelvic Health System as a covered treatment for stress, urgency and mixed urinary incontinence in women.

March 22, 2023
·
7 min read
Drug Development

Visus Therapeutics Completes Enrollment in BRIO-I, a Phase 3 Clinical Trial of BRIMOCHOL™ PF for the Treatment of Presbyopia

Visus Therapeutics Completes Enrollment in BRIO-I, a Phase 3 Clinical Trial of BRIMOCHOL ™ PF for the Treatment of Presbyopia.

March 22, 2023
·
4 min read
Drug Development

Alzamend Neuro Announces Completion of Clinical Portion of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Alzamend Neuro, Inc. today announced the completion of the clinical portion of its Phase IIA multiple ascending dose (“ MAD ”) study for dementia related to Alzheimer’s.

March 22, 2023
·
4 min read
Business

Pressure BioSciences Receives $1.5M Contract for UltraShear Nanoemulsified CBD

Pressure BioSciences, Inc. today announced the execution and launch of a manufacturing and distribution agreement (the “Agreement”).

March 22, 2023
·
7 min read
Business

TC Biopharm Announces Corporate Restructuring, Reduction in Overhead

TC BioPharm PLC announced a corporate restructuring plan to reduce costs and prioritize its pending lead US clinical programs.

March 22, 2023
·
4 min read
BioMidwest

Athersys Announces Successful Type B Meeting with the FDA

Athersys, Inc. announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B meeting with the U.S. Food & Drug Administration (FDA).

March 22, 2023
·
10 min read
Business

Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials

Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being developed for multiple B cell-mediated autoimmune and inflammatory diseases.

March 22, 2023
·
6 min read
Biotech Bay

Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023

Personalis, Inc. (Nasdaq: PSNL) today announced it is presenting new research data as scientific posters at the American Association for Cancer Research (AACR) Annual Meeting 2023, which convenes from April 14-19, 2023 in Orlando, Florida.

March 22, 2023
·
7 min read